VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2019 | Pregnancy outcomes in CML patients

Family planning is an important issue for chronic myeloid leukemia (CML) patients of childbearing potential, because they have a normal lifespan in the era of tyrosine kinase inhibitors; however, data on pregnancy cases in CML patients are scarce. Here, Ekaterina Chelysheva from the National Research Center for Hematology, Moscow, Russian Federation, discusses pregnancy outcomes in CML patients from an analysis of worldwide European Leukemia Net (ELN) registry data. This press briefing was recorded at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter